MOTS-C represents a recently identified mitochondrial peptide garnering significant research interest in metabolic and aging studies. Comprising merely 16 amino acids, this molecule appears across various tissues and circulates in plasma, indicating both local and systemic hormonal functions.
The peptide’s distinctiveness stems from its mitochondrial genome origin. Researchers suspect that MOTS-C becomes particularly active under metabolic stress conditions where the peptide could migrate from mitochondria to nucleus, influencing gene expression.
MOTS-C and Aging
Animal research indicates potential involvement in aging-related processes and metabolic decline. Expression levels appear age-dependent, with diminishing detection as organisms mature. The peptide reportedly interacts with established aging regulators including NAD⁺ and sirtuins.
MOTS-C and Muscles
Research demonstrates MOTS-C exposure enhances AMPK responses in muscle cells, potentially increasing glucose transporter expression for improved energy absorption and muscle performance.
MOTS-c and Fat Cells
High-fat diet studies in animal models associated MOTS-C with enhanced glucose utilization, amplified AMPK activation, and diminished fat accumulation. Treated mice exhibited noticeably reduced body fat and increased vitality.
MOTS-c and Bone Tissue
The peptide appears stimulating osteogenesis-related genes, namely ALP, Runx2, and Bglap. Bone marrow investigations documented MOTS-C promoting stem cell differentiation toward bone-forming phenotypes.
MOTS-C in Cardiovascular Context
Mouse model exposure to MOTS-c demonstrated improved endothelial reactivity, positioning it as an intriguing vascular health biomarker.
